cta-logo01
  • News

    Most Read

    • Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial
    • Apollomics begins dosing in Phase I AML treatment trial in China
    • Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B

    Most Recent

    Clinical Trials

    Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial

    05 Mar 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Cuba’s homegrown Covid-19 vaccines advance into late-stage trials
    • OCT West Coast: the post-pandemic outlook for clinical trials
    • OCT West Coast: Covid-19’s impact on clinical trials

    Most Recent

    Infectious Diseases

    Cuba’s homegrown Covid-19 vaccines advance into late-stage trials

    05 Mar 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Roche’s Evrysdi is a strong contender for SMA market share following EMA nod
    • Cuba’s homegrown Covid-19 vaccines advance into late-stage trials
    • Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial

    Most Recent

    Brands

    Roche’s Evrysdi is a strong contender for SMA market share following EMA nod

    05 Mar 2021
  • Themes
  • Deals

    Most Read

    • Altasciences completes acquisition of US-based CRO WCCT Global
    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink

    Most Recent

    Clinical Trials

    Altasciences completes acquisition of US-based CRO WCCT Global

    19 Feb 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kolabtree
    • VaLea Clinical Trials
    • Linari NanoTech

    Most Recent

    Clinical Trials

    Kolabtree

    24 Feb 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Pfizer to abort trials of Duchenne muscular dystrophy drug

Pfizer to abort trials of Duchenne muscular dystrophy drug

Pfizer has decided to abort two of its ongoing clinical trials evaluating domagrozumab (PF-06252616) for...

31st August 2018

Latest News

Clinical Trials

Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial

05 Mar 2021
Clinical Trials

Apollomics begins dosing in Phase I AML treatment trial in China

05 Mar 2021
Clinical Trials

Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B

05 Mar 2021
Clinical Trials

Marker Therapeutics treats first subject in acute myeloid leukaemia trial

04 Mar 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more